New Breed of Workstations Can Take On Bigger Tasks

By BIO-IT World


SCIENTIFIC COMPUTING · 64-bit processors and more memory provide a boost for handling huge data sets.

By Salvatore Salamone

November 14, 2004 | A new breed of scientific workstations is leading to a shift in how life scientists use such systems.

Unlike traditional workstations that for the most part have been built on proprietary technology, the new machines are based on commodity processors and widely used operating systems. Vendors including Apple, Dell, HP, IBM, SGI, and Sun Microsystems have recently introduced single- and dual-processor systems based on 64-bit Itanium, Opteron, or PowerPC G5 chips and running Linux, Windows, or Mac OS X operating systems. These machines offer very high computational power and the ability to access much more memory than their 32-bit counterparts. This makes them suitable to run many data analysis, visualization, and computationally intense applications such as molecular-modeling routines.

As vendors have taken a more open-systems approach, their workstations come with standardized components such as graphics accelerator cards and operating systems with a familiar user interface. This "commodification" allows researchers to focus on their work, rather than spending most of their time developing and porting software or deciding which add-on hardware to buy.


WALL-TO-WALL DATA: Powered by Opteron-based Sun workstations, UC San Diego's BioWall displays very high-resolution data.
"This trend turns the workstation into a tool," says Juan Vega, senior manager, Dell Precision Worldwide Marketing. "Just as a carpenter focuses on [his] work and not on chisel design, we have people telling us, 'Provide a system for our applications, and don't make us pick a graphics card.'"


New Systems, New Applications 
The combination of high performance, component standardization, and the ability to access large amounts of memory makes the new workstations attractive for many computationally intensive scientific applications.

That's the case with a University of California at San Diego project called the BioWall. "We chose [Opteron-based] Sun Java workstations because of their performance, ability to handle large amounts of memory per node, stability, and compatibility with QuadroFX graphics," says David Lee, UCSD's BioWall application engineer.

The BioWall uses 20 high-resolution flat-panel displays mounted on a wall in a pattern of five across and four high. The BioWall is being used to display very high-resolution data sets generated by electron and multi-photon light microscopes at the National Center for Microscopy and Imaging Research. The data associated with the images range from several gigabytes for a 2-D picture to several hundred gigabytes for 3-D data sets. Researchers use the system regularly in collaborative meetings.

"The resolution and size of the BioWall gives them a very large digital port-hole into their data," Lee says. He notes that the benefits of this high-resolution tiled display can be illustrated in two specific applications: exploring large 2-D brain maps produced by a multi-photon light microscope, and viewing large 3-D volumes from a transmission electron microscope.

Taking a different approach is startup Orion Multisystems, which recently announced its first products: 12-node and 96-node Linux clusters in a workstation form factor. Within the life sciences, Orion sees the systems being used in two basic scenarios. One, a single scientist or group could use the cluster to speed up computational work that might previously have been done on a standalone PC. Two, researchers could use the Orion hardware for applications development, building and testing applications on a real Linux cluster before submitting them to their organization's production cluster.






White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.